Cargando…
Preclinical Modelling of PDA: Is Organoid the New Black?
Pancreatic ductal adenocarcinoma (PDA) is a malignancy of the exocrine pancreas with the worst prognosis among all solid tumours, and soon to become the second leading cause of cancer-related deaths. A more comprehensive understanding of the molecular mechanisms underlying this disease is crucial to...
Autores principales: | D’Agosto, Sabrina, Andreani, Silvia, Scarpa, Aldo, Corbo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600483/ https://www.ncbi.nlm.nih.gov/pubmed/31195689 http://dx.doi.org/10.3390/ijms20112766 |
Ejemplares similares
-
Generation of Pancreatic Organoid-Derived Isografts
por: D’Agosto, Sabrina, et al.
Publicado: (2020) -
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study
por: Nicosia, Luca, et al.
Publicado: (2020) -
Long-term organoid culture of a small intestinal neuroendocrine tumor
por: D’Agosto, Sabrina, et al.
Publicado: (2023) -
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
por: Del Curatolo, Anais, et al.
Publicado: (2018) -
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease
por: Filippini, Dea, et al.
Publicado: (2019)